REPORT ID 3810

EMEA (Europe, Middle East and Africa) Neuromodulation Devices Market Report 2017

Publish Date
14-Dec-17
Pages
109
Format
Electronic (PDF)

In this report, the EMEA Neuromodulation Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Neuromodulation Devices for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Neuromodulation Devices market competition by top manufacturers/players, with Neuromodulation Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Medtronic
    Boston Scientific Corporation
    St.Jude Medical
    Synapse Biomedical
    Nevro
    Neurosigma
    Neuropace
    Neuronetics
    Cyberonics
    BioControl Medical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Deep Brain Stimulation (DBS) Systems
    Spinal Cord Stimulator (SCS) Systems
    Diaphragm Pacing System (DPS)
    Respiratory Electrical Stimulation (RES)
    Vagus Nerve Stimulation (VNS)
    Gastric Electrical Stimulation (GES)
    Transcranial Magnetic Stimulation (TMS)
    Transcutaneous Electrical Nerve Stimulation (TENS)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Chronic Pain
    Parkinson's Disease
    Urine Incontinence
    Epilepsy
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Neuromodulation Devices Market Report 2017
1 Neuromodulation Devices Overview
    1.1 Product Overview and Scope of Neuromodulation Devices
    1.2 Classification of Neuromodulation Devices
        1.2.1 EMEA Neuromodulation Devices Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Neuromodulation Devices Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Deep Brain Stimulation (DBS) Systems
        1.2.4 Spinal Cord Stimulator (SCS) Systems
        1.2.5 Diaphragm Pacing System (DPS)
        1.2.6 Respiratory Electrical Stimulation (RES)
        1.2.7 Vagus Nerve Stimulation (VNS)
        1.2.8 Gastric Electrical Stimulation (GES)
        1.2.9 Transcranial Magnetic Stimulation (TMS)
        1.2.10 Transcutaneous Electrical Nerve Stimulation (TENS)
    1.3 EMEA Neuromodulation Devices Market by Application/End Users
        1.3.1 EMEA Neuromodulation Devices Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Chronic Pain
        1.3.3 Parkinson's Disease
        1.3.4 Urine Incontinence
        1.3.5 Epilepsy
        1.3.6 Others
    1.4 EMEA Neuromodulation Devices Market by Region
        1.4.1 EMEA Neuromodulation Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Neuromodulation Devices (2012-2022)
        1.5.1 EMEA Neuromodulation Devices Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Neuromodulation Devices Revenue and Growth Rate (2012-2022)

2 EMEA Neuromodulation Devices Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Neuromodulation Devices Market Competition by Players/Manufacturers
        2.1.1 EMEA Neuromodulation Devices Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Neuromodulation Devices Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Neuromodulation Devices Sale Price by Players (2012-2017)
    2.2 EMEA Neuromodulation Devices (Volume and Value) by Type/Product Category
        2.2.1 EMEA Neuromodulation Devices Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Neuromodulation Devices Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Neuromodulation Devices Sale Price by Type (2012-2017)
    2.3 EMEA Neuromodulation Devices (Volume) by Application
    2.4 EMEA Neuromodulation Devices (Volume and Value) by Region
        2.4.1 EMEA Neuromodulation Devices Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Neuromodulation Devices Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Neuromodulation Devices Sales Price by Region (2012-2017)

3 Europe Neuromodulation Devices (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Neuromodulation Devices Sales and Value (2012-2017)
        3.1.1 Europe Neuromodulation Devices Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Neuromodulation Devices Revenue and Growth Rate (2012-2017)
    3.2 Europe Neuromodulation Devices Sales and Market Share by Type
    3.3 Europe Neuromodulation Devices Sales and Market Share by Application
    3.4 Europe Neuromodulation Devices Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Neuromodulation Devices Sales Volume by Countries (2012-2017)
        3.4.2 Europe Neuromodulation Devices Revenue by Countries (2012-2017)
        3.4.3 Germany Neuromodulation Devices Sales and Growth Rate (2012-2017)
        3.4.4 France Neuromodulation Devices Sales and Growth Rate (2012-2017)
        3.4.5 UK Neuromodulation Devices Sales and Growth Rate (2012-2017)
        3.4.6 Russia Neuromodulation Devices Sales and Growth Rate (2012-2017)
        3.4.7 Italy Neuromodulation Devices Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Neuromodulation Devices Sales and Growth Rate (2012-2017)

4 Middle East Neuromodulation Devices (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Neuromodulation Devices Sales and Value (2012-2017)
        4.1.1 Middle East Neuromodulation Devices Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Neuromodulation Devices Revenue and Growth Rate (2012-2017)
    4.2 Middle East Neuromodulation Devices Sales and Market Share by Type
    4.3 Middle East Neuromodulation Devices Sales and Market Share by Application
    4.4 Middle East Neuromodulation Devices Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Neuromodulation Devices Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Neuromodulation Devices Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Neuromodulation Devices Sales and Growth Rate (2012-2017)
        4.4.4 Israel Neuromodulation Devices Sales and Growth Rate (2012-2017)
        4.4.5 UAE Neuromodulation Devices Sales and Growth Rate (2012-2017)
        4.4.6 Iran Neuromodulation Devices Sales and Growth Rate (2012-2017)

5 Africa Neuromodulation Devices (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Neuromodulation Devices Sales and Value (2012-2017)
        5.1.1 Africa Neuromodulation Devices Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Neuromodulation Devices Revenue and Growth Rate (2012-2017)
    5.2 Africa Neuromodulation Devices Sales and Market Share by Type
    5.3 Africa Neuromodulation Devices Sales and Market Share by Application
    5.4 Africa Neuromodulation Devices Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Neuromodulation Devices Sales Volume by Countries (2012-2017)
        5.4.2 Africa Neuromodulation Devices Revenue by Countries (2012-2017)
        5.4.3 South Africa Neuromodulation Devices Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Neuromodulation Devices Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Neuromodulation Devices Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Neuromodulation Devices Sales and Growth Rate (2012-2017)

6 EMEA Neuromodulation Devices Manufacturers/Players Profiles and Sales Data
    6.1 Medtronic
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Neuromodulation Devices Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Medtronic Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Boston Scientific Corporation
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Neuromodulation Devices Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Boston Scientific Corporation Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 St.Jude Medical
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Neuromodulation Devices Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 St.Jude Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Synapse Biomedical
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Neuromodulation Devices Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Synapse Biomedical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Nevro
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Neuromodulation Devices Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Nevro Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Neurosigma
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Neuromodulation Devices Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Neurosigma Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Neuropace
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Neuromodulation Devices Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Neuropace Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Neuronetics
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Neuromodulation Devices Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Neuronetics Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Cyberonics
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Neuromodulation Devices Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Cyberonics Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 BioControl Medical
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Neuromodulation Devices Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 BioControl Medical Neuromodulation Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Neuromodulation Devices Manufacturing Cost Analysis
    7.1 Neuromodulation Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Neuromodulation Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Neuromodulation Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Neuromodulation Devices Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Neuromodulation Devices Market Forecast (2017-2022)
    11.1 EMEA Neuromodulation Devices Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Neuromodulation Devices Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Neuromodulation Devices Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Neuromodulation Devices Price and Trend Forecast (2017-2022)
    11.2 EMEA Neuromodulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Neuromodulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Neuromodulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Neuromodulation Devices Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Neuromodulation Devices Sales Forecast by Type (2017-2022)
    11.7 EMEA Neuromodulation Devices Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer